Validated RP-HPLC analysis of irinotecan HCI in the bulk material and in pharmaceutical formulations

Validated RP-HPLC analysis of irinotecan HCI in the bulk material and in pharmaceutical formulations

An isocratic reversed-phase high-performance liquid chromatographic (RPHPLC) method for analysis of irinotecan HCI has been developed and validated. Separation was achieved on a C sub(18) column with potassium dihydrogen phosphate buffer (pH adjusted to 3.5 with orthophosphoric acid)-acetonitrile-me...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta chromatographica 2009-03, Vol.21 (1), p.71-82
Hauptverfasser: Shende, P, Gaud, R
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 82
container_issue 1
container_start_page 71
container_title Acta chromatographica
container_volume 21
creator Shende, P
Gaud, R
description An isocratic reversed-phase high-performance liquid chromatographic (RPHPLC) method for analysis of irinotecan HCI has been developed and validated. Separation was achieved on a C sub(18) column with potassium dihydrogen phosphate buffer (pH adjusted to 3.5 with orthophosphoric acid)-acetonitrile-methanol 55:25:20 (v/v) as mobile phase at a flow rate of 1.0 mL min super(-1). UV detection was performed at 254 nm. The method is simple, sensitive, rapid, and selective, and linear over the range 30-70 mu g mL super(-1) for assay of irinotecan HCI. The precision of the assay method was below 1.0% RSD. Mean recovery was in the range 98.0-102.0%. Recovery of the active pharmaceutical ingredient from dosage forms ranged from 99.0 to 101.0. The method is useful for quality control in bulk manufacture and of the pharmaceutical formulation.
doi_str_mv 10.1556/AChrom.21.2009.1.6
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_21279131</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>21279131</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_212791313</originalsourceid><addsrcrecordid>eNqNi71OwzAURj0UiUJ5ASZPbDH-aVI6oggUpA4VQl2rS-Iot_VP8bUH3p4g8QBMn3TO-Ri7V1Koum4en9spRS-0ElrKrVCiWbCl0sZU2tTNNbshOkmp6_X6acmGAzgcINuBv--rbr9rOQRw34TE48gxYYjZ9hB4175xDDxPln8Wd-Z-PiUEN_fDr7hMkDz0tmTsZzrG5IuDjDHQil2N4Mje_e0te3h9-Wi76pLiV7GUjx6pt85BsLHQUSu92SqjzL_DH509Tmk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21279131</pqid></control><display><type>article</type><title>Validated RP-HPLC analysis of irinotecan HCI in the bulk material and in pharmaceutical formulations</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Shende, P ; Gaud, R</creator><creatorcontrib>Shende, P ; Gaud, R</creatorcontrib><description>An isocratic reversed-phase high-performance liquid chromatographic (RPHPLC) method for analysis of irinotecan HCI has been developed and validated. Separation was achieved on a C sub(18) column with potassium dihydrogen phosphate buffer (pH adjusted to 3.5 with orthophosphoric acid)-acetonitrile-methanol 55:25:20 (v/v) as mobile phase at a flow rate of 1.0 mL min super(-1). UV detection was performed at 254 nm. The method is simple, sensitive, rapid, and selective, and linear over the range 30-70 mu g mL super(-1) for assay of irinotecan HCI. The precision of the assay method was below 1.0% RSD. Mean recovery was in the range 98.0-102.0%. Recovery of the active pharmaceutical ingredient from dosage forms ranged from 99.0 to 101.0. The method is useful for quality control in bulk manufacture and of the pharmaceutical formulation.</description><identifier>ISSN: 1233-2356</identifier><identifier>DOI: 10.1556/AChrom.21.2009.1.6</identifier><language>eng</language><ispartof>Acta chromatographica, 2009-03, Vol.21 (1), p.71-82</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Shende, P</creatorcontrib><creatorcontrib>Gaud, R</creatorcontrib><title>Validated RP-HPLC analysis of irinotecan HCI in the bulk material and in pharmaceutical formulations</title><title>Acta chromatographica</title><description>An isocratic reversed-phase high-performance liquid chromatographic (RPHPLC) method for analysis of irinotecan HCI has been developed and validated. Separation was achieved on a C sub(18) column with potassium dihydrogen phosphate buffer (pH adjusted to 3.5 with orthophosphoric acid)-acetonitrile-methanol 55:25:20 (v/v) as mobile phase at a flow rate of 1.0 mL min super(-1). UV detection was performed at 254 nm. The method is simple, sensitive, rapid, and selective, and linear over the range 30-70 mu g mL super(-1) for assay of irinotecan HCI. The precision of the assay method was below 1.0% RSD. Mean recovery was in the range 98.0-102.0%. Recovery of the active pharmaceutical ingredient from dosage forms ranged from 99.0 to 101.0. The method is useful for quality control in bulk manufacture and of the pharmaceutical formulation.</description><issn>1233-2356</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNqNi71OwzAURj0UiUJ5ASZPbDH-aVI6oggUpA4VQl2rS-Iot_VP8bUH3p4g8QBMn3TO-Ri7V1Koum4en9spRS-0ElrKrVCiWbCl0sZU2tTNNbshOkmp6_X6acmGAzgcINuBv--rbr9rOQRw34TE48gxYYjZ9hB4175xDDxPln8Wd-Z-PiUEN_fDr7hMkDz0tmTsZzrG5IuDjDHQil2N4Mje_e0te3h9-Wi76pLiV7GUjx6pt85BsLHQUSu92SqjzL_DH509Tmk</recordid><startdate>20090301</startdate><enddate>20090301</enddate><creator>Shende, P</creator><creator>Gaud, R</creator><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20090301</creationdate><title>Validated RP-HPLC analysis of irinotecan HCI in the bulk material and in pharmaceutical formulations</title><author>Shende, P ; Gaud, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_212791313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shende, P</creatorcontrib><creatorcontrib>Gaud, R</creatorcontrib><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Acta chromatographica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shende, P</au><au>Gaud, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Validated RP-HPLC analysis of irinotecan HCI in the bulk material and in pharmaceutical formulations</atitle><jtitle>Acta chromatographica</jtitle><date>2009-03-01</date><risdate>2009</risdate><volume>21</volume><issue>1</issue><spage>71</spage><epage>82</epage><pages>71-82</pages><issn>1233-2356</issn><abstract>An isocratic reversed-phase high-performance liquid chromatographic (RPHPLC) method for analysis of irinotecan HCI has been developed and validated. Separation was achieved on a C sub(18) column with potassium dihydrogen phosphate buffer (pH adjusted to 3.5 with orthophosphoric acid)-acetonitrile-methanol 55:25:20 (v/v) as mobile phase at a flow rate of 1.0 mL min super(-1). UV detection was performed at 254 nm. The method is simple, sensitive, rapid, and selective, and linear over the range 30-70 mu g mL super(-1) for assay of irinotecan HCI. The precision of the assay method was below 1.0% RSD. Mean recovery was in the range 98.0-102.0%. Recovery of the active pharmaceutical ingredient from dosage forms ranged from 99.0 to 101.0. The method is useful for quality control in bulk manufacture and of the pharmaceutical formulation.</abstract><doi>10.1556/AChrom.21.2009.1.6</doi></addata></record>
fulltext fulltext
identifier ISSN: 1233-2356
ispartof Acta chromatographica, 2009-03, Vol.21 (1), p.71-82
issn 1233-2356
language eng
recordid cdi_proquest_miscellaneous_21279131
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
title Validated RP-HPLC analysis of irinotecan HCI in the bulk material and in pharmaceutical formulations
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T08%3A21%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Validated%20RP-HPLC%20analysis%20of%20irinotecan%20HCI%20in%20the%20bulk%20material%20and%20in%20pharmaceutical%20formulations&rft.jtitle=Acta%20chromatographica&rft.au=Shende,%20P&rft.date=2009-03-01&rft.volume=21&rft.issue=1&rft.spage=71&rft.epage=82&rft.pages=71-82&rft.issn=1233-2356&rft_id=info:doi/10.1556/AChrom.21.2009.1.6&rft_dat=%3Cproquest%3E21279131%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=21279131&rft_id=info:pmid/&rfr_iscdi=true